Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis
Digestive and Liver Disease · 2023-11 · 55 (11) · 1543-1547
DOI: 10.1016/j.dld.2023.08.037 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2023-11. Verfasst von Michael Praktiknjo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine B, University Hospital Münster, Germany; Department of Internal Medicine I, University Hospital Bonn, Germany. Electr…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Liver Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Rheinische Friedrich-Wilhelms-Universität Bonn.
Abstract (Originalsprache)
BACKGROUND: Primary Sclerosing Cholangitis (PSC) is a progressive cholestatic liver disease with liver transplantation (LT) as the only curative therapy. Some regions use body-weight-loss as standard-exception criteria for organ allocation but data on the impact of body composition on survival of patients with PSC is scarce. METHODS: Abdominal MRI of PSC patients were quantitatively analyzed for intramuscular fat fraction (IMFF) as surrogate of myosteatosis. Clinical and laboratory data were retrieved from patient records. Primary outcome was transplant-free survival (TFS). RESULTS: 116 PSC patients were included. Median age was 38 (18-71) years with 74 (64%) male patients. 15 (13%) patients had significant weigh loss. IMFF was significantly associated with survival. Multivariate regression analysis showed IMFF ≥ 15% as independent predictor for TFS (p = 0.032, HR 3.215 CI 1.104-9.366), but not significant weight loss (p = 0.618). CONCLUSION: IMFF is independently associated with TFS in patients with PSC and may identify patients with more urgent need for LT. NCT03584204.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine B, University Hospital Münster, Germany; Department of Internal Medicine I, University Hospital Bonn, Germany. Electronic address: michael.praktiknjo@ukmuenster.de.
- Department of Internal Medicine I, University Hospital Bonn, Germany.
- Department of Internal Medicine B, University Hospital Münster, Germany.
- Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Germany.
- Department of Internal Medicine I, University Hospital Bonn, Germany; Department of Internal Medicine, Gastroenterology and Oncology, Vivantes Humboldt Hospital Berlin, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Ernst und Berta Grimmke Stiftung
Zitieren
APA
Praktiknjo, M., Zhou, T., Krüsken, M., Jacob, T., Sprinkart, A. M., Nowak, S., Kimmann, M., Dold, L., Chang, J., Jansen, C., Strassburg, C. P., Luetkens, J., & Weismüller, T. J. (2023). Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis. Digestive and Liver Disease, 55(11), 1543-1547. https://doi.org/10.1016/j.dld.2023.08.037
Vancouver
Praktiknjo M, Zhou T, Krüsken M, Jacob T, Sprinkart AM, Nowak S, et al. Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis. Digestive and Liver Disease. 2023;55(11):1543-1547. doi:10.1016/j.dld.2023.08.037
BibTeX
@article{Praktiknjo2023,
author = {Praktiknjo, Michael and Zhou, Taotao and Krüsken, Maximiliane and Jacob, Torid and Sprinkart, Alois M and Nowak, Sebastian and Kimmann, Markus and Dold, Leona and Chang, Johannes and Jansen, Christian and Strassburg, Christian P and Luetkens, Julian and Weismüller, Tobias J},
title = {Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis},
journal = {Digestive and Liver Disease},
year = {2023},
volume = {55},
number = {11},
pages = {1543--1547},
doi = {10.1016/j.dld.2023.08.037}
}
EUVIMED